Latest

Market news by symbol, source, and language

20 stories
tmx_newsfile

MultiSensor AI Appoints James Newman as Vice President of Strategy and Product to Advance Customer-Centered Innovation and Growth

Newman brings more than 25 years of industrial technology experience, with deep expertise in AI-driven SaaS product strategyHouston, Texas--(Newsfile Corp. - July 7, 2026) - MultiSensor AI Holdings, Inc. NASDAQ:MSAI ("MultiSensor AI," "MSAI," or the "Company"), a pioneer in early threat detection a…

TMX Newsfile en_IN
StocksUS
reuters

Private credit investors play chicken with tenders

By Stephen GandelGetting harder-to-sell assets into mom-and-pop investment portfolios turned out to be the easy part. It’s getting them out that’s difficult.Non-traded private credit funds marketed to rich individuals have ballooned into a $300 billion pool of money. Now, those small-fry savers are…

Reuters en_IN
ETFsStocksUS
globenewswire

SurancePlus Successfully Closes on Five (5) RWA Securities Offerings on Solana Raising $7.1 million and Expanding Tokenized RWA Platform

GRAND CAYMAN, Cayman Islands, July 07, 2026 (GLOBE NEWSWIRE) -- Oxbridge Re Holdings Limited (NASDAQ: OXBR), (the “Company”), a leader in digitizing reinsurance securities as tokenized real-world assets (RWAs), together with its subsidiary SurancePlus, today announced the successful completion of f…

GlobeNewswire en_IN
Crypto
prnewswire

Autoliv and XPENG Partner to Advance Safer Mobility Worldwide

GUANGZHOU, China, July 7, 2026 /PRNewswire/ -- Autoliv, Inc. (NYSE:ALV) (SSE: ALIVsdb), the global leader in automotive safety systems, today announced that XPENG Inc, a leading Chinese physical AI technology company with growing international presence, and Autoliv (Shanghai) Management Co., Ltd…

PR Newswire en_IN
StocksCN

REG - JPMorgan EM G&I Plc - Director/PDMR Shareholding

RNS Number : 3600L JPMorgan Emerg Mkts Growth & Income 07 July 2026  JPMorgan Emerging Markets Growth & Income plc(the 'Company')Legal Entity Identifier: 5493001VPQDYH1SSSR77Information disclosed in accordance with DTR 3.1.2-A, incorporating Article 19(1) of the Market Abuse Regulation07 July 20…

London Stock Exchange en_IN
ETFsStocksGB

Valentino plans €450 million bond sale to refinance loan, filing shows

Italian fashion house Valentino is planning to sell a €450 million ($514 million) bond by the end of August to refinance existing bank debt, according to a corporate filing.Revenues and earnings at the Italian luxury group declined further last year, prompting shareholders Mayhoola and French luxur…

Reuters en_IN
corp_bondStocksIT
NEWS reuters

French court shortens Le Pen's ban from office but orders electronic tag

A French appeals court on Tuesday upheld Marine Le Pen's conviction for misusing EU funds but shortened her ban on running for elected office, potentially re-opening a path for the far-right leader to run in the 2027 presidential race.However, the court ruled Le Pen serve a three-year jail term. Al…

Reuters en_IN
NEWS modular_finance

ZymIQ signs exclusive distribution agreement with Imazo for Kalzyme in the Nordics

ZymIQ Technology AB has signed an exclusive distribution agreement with Imazo AB for the Kalzyme® brand in the Nordic market. The agreement covers Kalzyme's own range of animal health products in the Nordic market and includes Sweden, Norway, Denmark and Finland.Kalzyme® is a range of enzyme based…

MFN by Modular Finance en_IN
ETFsStocksSE
prnewswire

Vector Science & Therapeutics Announces Landmark Exclusive cGMP Manufacturing Agreement with LyoGenesis Plus for Its Proprietary Peptide Portfolio

MEQUON, Wis., July 7, 2026 /CNW/ -- Vector Science & Therapeutics Corp. (TSXV:PAIN) ("Vector" or the "Company") today announced an exclusive licensing and manufacturing agreement with LyoGenesis Plus ("LyoGenesis"), a cGMP lyophilization and manufacturing partner based in Mequon, Wisconsin. Under t…

PR Newswire en_IN
ETFsStocksCA
prnewswire

Vector Science & Therapeutics Announces Landmark Exclusive cGMP Manufacturing Agreement with LyoGenesis Plus for Its Proprietary Peptide Portfolio

MEQUON, Wis., July 7, 2026 /PRNewswire/ -- Vector Science & Therapeutics Corp. (TSXV:PAIN) ("Vector" or the "Company") today announced an exclusive licensing and manufacturing agreement with LyoGenesis Plus ("LyoGenesis"), a cGMP lyophilization and manufacturing partner based in Mequon, Wisconsin…

PR Newswire en_IN
ETFsStocksCA